Renaissance Technologies’s Indaptus Therapeutics INDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,018
| Closed | -$15.7K | – | 3709 |
|
|
2025
Q1 | $15.7K | Buy |
1,018
+29
| +3% | +$669 | ﹤0.01% | 3372 |
|
|
2024
Q4 | $23.3K | Buy |
989
+21
| +2% | +$667 | ﹤0.01% | 3473 |
|
|
2024
Q3 | $33.6K | Buy |
968
+18
| +2% | +$884 | ﹤0.01% | 3388 |
|
|
2024
Q2 | $56.4K | Buy |
950
+18
| +2% | +$1.2K | ﹤0.01% | 3272 |
|
|
2024
Q1 | $58K | Sell |
932
-118
| -11% | -$6.28K | ﹤0.01% | 3457 |
|
|
2023
Q4 | $52K | Buy |
1,050
+179
| +21% | +$11.3K | ﹤0.01% | 3447 |
|
|
2023
Q3 | $67K | Buy |
871
+128
| +17% | +$8.65K | ﹤0.01% | 3336 |
|
|
2023
Q2 | $40K | Buy |
743
+57
| +8% | +$3.33K | ﹤0.01% | 3653 |
|
|
2023
Q1 | $36K | Buy |
686
+4
| +0.6% | +$189 | ﹤0.01% | 3729 |
|
|
2022
Q4 | $28K | Sell |
682
-22
| -3% | -$1.11K | ﹤0.01% | 3901 |
|
|
2022
Q3 | $43K | Buy |
704
+4
| +0.6% | +$312 | ﹤0.01% | 3790 |
|
|
2022
Q2 | $51K | Buy |
+700
| New | +$54.7K | ﹤0.01% | 3993 |
|
|
2021
Q1 | – | Sell |
-332
| Closed | -$128K | – | 3493 |
|
|
2020
Q4 | $128K | Buy |
332
+324
| +4,050% | +$141K | ﹤0.01% | 3223 |
|
|
2020
Q3 | $4K | Sell |
8
-485
| -98% | -$356K | ﹤0.01% | 3333 |
|
|
2020
Q2 | $313K | Buy |
493
+369
| +298% | +$228K | ﹤0.01% | 3026 |
|
|
2020
Q1 | $55K | Buy |
+124
| New | +$93.7K | ﹤0.01% | 3310 |
|
|
2019
Q3 | – | Sell |
-61
| Closed | -$593K | – | 3553 |
|
|
2019
Q2 | $593K | Buy |
+61
| New | +$769K | ﹤0.01% | 2924 |
|
|
2018
Q4 | – | Sell |
-19
| Closed | -$244K | – | 3486 |
|
|
2018
Q3 | $244K | Sell |
19
-21
| -53% | -$200K | ﹤0.01% | 3086 |
|
|
2018
Q2 | $391K | Buy |
40
+33
| +471% | +$366K | ﹤0.01% | 2904 |
|
|
2018
Q1 | $96K | Sell |
7
-53
| -88% | -$751K | ﹤0.01% | 3265 |
|
|
2017
Q4 | $688K | Buy |
60
+24
| +67% | +$372K | ﹤0.01% | 2808 |
|
|
2017
Q3 | $720K | Buy |
36
+24
| +200% | +$346K | ﹤0.01% | 2692 |
|
|
2017
Q2 | $154K | Buy |
12
+6
| +100% | +$72.8K | ﹤0.01% | 3034 |
|
|
2017
Q1 | $66K | Buy |
6
+1
| +20% | +$11.1K | ﹤0.01% | 3121 |
|
|
2016
Q4 | $64K | Sell |
5
-7
| -58% | -$81.7K | ﹤0.01% | 3146 |
|
|
2016
Q3 | $154K | Buy |
+12
| New | +$149K | ﹤0.01% | 3113 |
|
Other funds holding INDP
SS
TRCT
Renaissance Technologies's INDP Position: Q2 2025 in Review
Renaissance Technologies sold out of Indaptus Therapeutics (INDP) in Q2 2025, closing a stake of 1,018 shares — an estimated $15.7K sold.
Renaissance Technologies first reported a position in INDP in Q3 2016 and held it in 26 quarters. The position peaked at $720K in Q3 2017. 5 funds tracked by Wall St. Rank hold INDP as of Q2 2025.
- Renaissance Technologies reported no remaining Indaptus Therapeutics position as of Q2 2025 after selling out during the quarter.
- Renaissance Technologies sold 1,018 Indaptus Therapeutics shares in Q2 2025, an estimated $15.7K.
- Renaissance Technologies first reported a position in Indaptus Therapeutics in Q3 2016 and held it in 26 quarters.
- Renaissance Technologies's Indaptus Therapeutics position peaked at $720K in Q3 2017.
- 5 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q2 2025.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.